Labcorp to present diverse portfolio of precision oncology research at the annual meeting of the american association for cancer research

Researchers to present on topics ranging from molecular residual disease and immunotherapy to whole-genome sequencing burlington, n.c. , april 2, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, will present abstracts in the areas of immunology, cellular biology, genomics and liquid biopsy at the annual meeting of the american association for cancer research® (aacr®) in san diego (april 5-10, 2024).
LH Ratings Summary
LH Quant Ranking